Physician
Chabot, Stephen
Chabot, Stephen was paid $270K by Medicaid between Jan 2018 and Apr 2022, across 6 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoCHABOT, STEPHEN
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1609847078assigned 02/01/2006
33bProvider typePsychiatry Physician
28Total paid$270K
24GClaims2,519
24DCodes billed6
24AFirst – last monthJan 2018 – Apr 2022
Compared with peers
Next to other Psychiatry Physician providers in Rhode Island
Rank by total paid#21 of 140
Median peer was paid$50K
This provider vs. median5.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 841 | $79K | |
| 2019 | 765 | $90K | |
| 2020 | 792 | $92K | |
| 2021 | 86 | $7K | |
| 2022 | 35 | $3K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 932 | 608 | $76K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 27% | 390 | 252 | $73K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 19% | 418 | 269 | $52K |
| H0019 | Behavioral health; long-term residential (non-medical, non-acute care in a residential treatment program where stay is typically longer than 30 days), without room and board, per diem | 17% | 433 | 18 | $45K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 7.2% | 276 | 251 | $19K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2.3% | 70 | 58 | $6K |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.